5AM Venture Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-462,286
| Closed | -$13.7M | – | 27 |
|
|
2023
Q3 | $13.7M | Sell |
462,286
-400,000
| -46% | -$11.9M | 3.96% | 6 |
|
|
2023
Q2 | $15.5M | Hold |
862,286
| – | – | 3.87% | 7 |
|
|
2023
Q1 | $13.8M | Hold |
862,286
| – | – | 3.54% | 5 |
|
|
2022
Q4 | $15.8M | Hold |
862,286
| – | – | 4.24% | 8 |
|
|
2022
Q3 | $16.9M | Hold |
862,286
| – | – | 3.24% | 10 |
|
|
2022
Q2 | $16.1M | Hold |
862,286
| – | – | 3.98% | 11 |
|
|
2022
Q1 | $18.9M | Hold |
862,286
| – | – | 4.13% | 9 |
|
|
2021
Q4 | $24.5M | Sell |
862,286
-500,000
| -37% | -$14.2M | 4.6% | 9 |
|
|
2021
Q3 | $28.7M | Hold |
1,362,286
| – | – | 5.82% | 9 |
|
|
2021
Q2 | $25.7M | Hold |
1,362,286
| – | – | 6.46% | 6 |
|
|
2021
Q1 | $20.8M | Hold |
1,362,286
| – | – | 3.75% | 8 |
|
|
2020
Q4 | $19.2M | Hold |
1,362,286
| – | – | 6.47% | 7 |
|
|
2020
Q3 | $21.3M | Hold |
1,362,286
| – | – | 5.61% | 8 |
|
|
2020
Q2 | $23.9M | Sell |
1,362,286
-500,000
| -27% | -$8.76M | 5.23% | 8 |
|
|
2020
Q1 | $27.4M | Sell |
1,862,286
-500,000
| -21% | -$7.35M | 8.48% | 4 |
|
|
2019
Q4 | $59.3M | Buy |
+2,362,286
| New | +$59.3M | 12.75% | 3 |
|